AbbVie Inc. (ABBV) vs Broadcom Inc. (AVGO)
A side-by-side comparison of AbbVie Inc. and Broadcom Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 10, 2026. Differences are shown without an overall score or investment verdict.
Different business models: ABBV is classified in Healthcare; AVGO is classified in Technology. Margin, capital intensity, and valuation differences should be interpreted in that sector context.
ABBV
AbbVie Inc.
$257.06HealthcareDelayed quote: Sep 11, 2026, 4:00 PM EDT
AVGO
Broadcom Inc.
$361.99TechnologyDelayed quote: Sep 11, 2026, 4:00 PM EDT
Total return — ABBV vs AVGO
growth of $100 · dividends reinvested · last 10yABBV +507.0% (+19.8%/yr)AVGO +2580.2% (+38.9%/yr)AVGO compounded faster over this window
ABBV AVGO
ABBV vs AVGO: by the numbers
- •AVGO is the larger company ($1.72T vs $454.17B market cap).
- •AVGO trades at the lower trailing earnings multiple (46.23 vs 72.43 P/E), one valuation lens rather than an overall verdict.
- •AVGO converts more revenue to profit (42.94% vs 9.81% net margin).
- •AVGO grew revenue faster over the past five years (27.42% vs 3.69% CAGR).
- •ABBV pays the higher dividend yield (2.68% vs 0.70%).
Metrics side by side
Valuation
| Metric | ABBV | AVGO |
|---|---|---|
| P/E ratio | 72.43 | 46.23 |
| Forward P/E | 18.32 | 31.17 |
| P/S ratio | 7.05 | 19.33 |
| P/B ratio | N/A | 17.28 |
| EV / EBITDA | 19.34 | 33.95 |
| FCF yield | 3.99% | 2.29% |
Profitability
| Metric | ABBV | AVGO |
|---|---|---|
| Gross margin | 71.48% | 67.66% |
| Operating margin | 29.32% | 39.89% |
| Net margin | 9.81% | 42.94% |
| ROE | N/A | 38.38% |
| ROIC | 13.46% | 23.99% |
Dividends
| Metric | ABBV | AVGO |
|---|---|---|
| Dividend yield | 2.68% | 0.70% |
| Payout ratio | 192.43% | 32.44% |
Growth (annualized)
| Metric | ABBV | AVGO |
|---|---|---|
| Revenue CAGR (5Y) | 3.69% | 27.42% |
| EPS CAGR (5Y) | -2.79% | 49.36% |
| FCF CAGR (5Y) | 0.11% | 24.60% |
| Total return CAGR (5Y) | 23.51% | 51.41% |
Frequently asked
- Which has the lower trailing P/E, ABBV or AVGO?
- AVGO has the lower trailing P/E: ABBV trades at 72.43 and AVGO at 46.23. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, ABBV or AVGO?
- Over the past five years, AVGO grew revenue faster — ABBV at a 3.69% CAGR versus AVGO at 27.42%.
- Does ABBV or AVGO pay a bigger dividend?
- ABBV yields 2.68% and AVGO yields 0.70% based on trailing dividends and the latest price.
- Is ABBV or AVGO more profitable?
- AVGO runs the higher net margin — ABBV at 9.81% versus AVGO at 42.94%.
- How have ABBV and AVGO total returns compared?
- Over the past 10 years, ABBV delivered 19.76% and AVGO delivered 39.97% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
AbbVie P/E ratioBroadcom P/E ratioAbbVie dividend yieldBroadcom dividend yieldAbbVie ROEBroadcom ROEAbbVie operating marginBroadcom operating marginAbbVie revenue growthBroadcom revenue growthAbbVie free cash flowBroadcom free cash flow
AbbVie & Broadcom appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 10, 2026.